- Home
- HKPD vs CRIS Comparison
HKPD vs CRIS Comparison
Compare HKPD & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- CRIS
- Stock Information
- Founded
- HKPD 2016
- CRIS 2000
- Country
- HKPD Hong Kong
- CRIS United States
- Employees
- HKPD N/A
- CRIS N/A
- Industry
- HKPD Other Pharmaceuticals
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HKPD Health Care
- CRIS Health Care
- Exchange
- HKPD Nasdaq
- CRIS Nasdaq
- Market Cap
- HKPD 20.9M
- CRIS 21.3M
- IPO Year
- HKPD 2025
- CRIS 2000
- Fundamental
- Price
- HKPD $1.28
- CRIS $1.81
- Analyst Decision
- HKPD
- CRIS Strong Buy
- Analyst Count
- HKPD 0
- CRIS 2
- Target Price
- HKPD N/A
- CRIS $16.50
- AVG Volume (30 Days)
- HKPD 854.5K
- CRIS 137.6K
- Earning Date
- HKPD 01-01-0001
- CRIS 07-31-2025
- Dividend Yield
- HKPD N/A
- CRIS N/A
- EPS Growth
- HKPD N/A
- CRIS N/A
- EPS
- HKPD 0.21
- CRIS N/A
- Revenue
- HKPD $20,770,344.00
- CRIS $11,202,000.00
- Revenue This Year
- HKPD N/A
- CRIS N/A
- Revenue Next Year
- HKPD N/A
- CRIS $10.67
- P/E Ratio
- HKPD $5.76
- CRIS N/A
- Revenue Growth
- HKPD 32.91
- CRIS 14.17
- 52 Week Low
- HKPD $0.81
- CRIS $1.02
- 52 Week High
- HKPD $3.79
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- HKPD N/A
- CRIS 36.90
- Support Level
- HKPD N/A
- CRIS $1.50
- Resistance Level
- HKPD N/A
- CRIS $2.48
- Average True Range (ATR)
- HKPD 0.00
- CRIS 0.21
- MACD
- HKPD 0.00
- CRIS -0.07
- Stochastic Oscillator
- HKPD 0.00
- CRIS 25.20
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.